Orexigen Therapeutics, Inc. Business Finance Contracts & Agreements
25 Contracts & Agreements
- Credit Agreements (1 contract)
- Exchange Agreements (3)
- Indenture Agreements (7)
- Note Agreements (2)
- Purchase Agreements (3)
- Security Agreements (2)
- Stock Agreements (3)
- Underwriting Agreements (1)
- Warrant Agreements (3)
- Amendment to the Asset Purchase Agreement, dated as of July 26, 2018, by and between Orexigen Therapeutics, Inc. and Nalpropion Pharmaceuticals, Inc (Filed With SEC on July 31, 2018)
- Asset Purchase Agreement, dated as of April 23, 2018, by and between Orexigen Therapeutics, Inc. and Nalpropion Pharmaceuticals, Inc. (Schedules and exhibits have been omitted... (Filed With SEC on April 24, 2018)
- Instrument of Resignation, Appointment and Acceptance, dated as of March 20, 2018, by and among Orexigen Therapeutics, Inc., Wilmington Savings Fund Society, FSB and U.S. Bank... (Filed With SEC on March 23, 2018)
- Debtor in Possession Credit and Security Agreement, dated as of March 12, 2018, by and between the Company, Wilmington Trust, National Association, as administrative agent, and... (Filed With SEC on March 12, 2018)
- Form of Exchange Agreement (Filed With SEC on December 1, 2017)
- Orexigen Therapeutics, Inc. Shares of Common Stock (par value$0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on March 30, 2017)
- OREXIGEN THERAPEUTICS, INC. asissuer U.S. BANK NATIONAL ASSOCIATION INDENTURE Dated as ofFebruary 23, 2017 2.75% CONVERTIBLE EXCHANGE SENIOR NOTES DUE 2020 Table of Contents (Filed With SEC on February 24, 2017)
- SECONDSUPPLEMENTAL INDENTURE (Filed With SEC on February 17, 2017)
- OREXIGEN THERAPEUTICS, INC. asissuer U.S. BANK NATIONAL ASSOCIATION INDENTURE Dated as ofFebruary 23, 2017 2.75% CONVERTIBLE EXCHANGE SENIOR NOTES DUE 2020 Table of Contents (Filed With SEC on February 17, 2017)
- FIRST SUPPLEMENTAL INDENTURE (Filed With SEC on December 20, 2016)
- SECURITY AGREEMENT among OREXIGENTHERAPEUTICS, INC., as Issuer, and THE GUARANTORSPARTY HERETO FROM TIME TO TIME, as Guarantors and U.S. BANK NATIONALASSOCIATION, as Collateral... (Filed With SEC on March 25, 2016)
- OREXIGEN THERAPEUTICS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee and Collateral Agent INDENTURE Dated as ofMarch 21, 2016 0% Convertible Senior Secured Notes due 2020... (Filed With SEC on March 25, 2016)
- SECURITY AGREEMENT among OREXIGENTHERAPEUTICS, INC., as Issuer, and THE GUARANTORSPARTY HERETO FROM TIME TO TIME, as Guarantors and U.S. BANK NATIONALASSOCIATION, as Collateral... (Filed With SEC on March 15, 2016)
- [FORM OF FACE OF NOTE] [INCLUDEFOLLOWING LEGEND IF A GLOBAL NOTE] (Filed With SEC on March 15, 2016)
- FORM OF WARRANT (Filed With SEC on March 15, 2016)
- OREXIGEN THERAPEUTICS, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee and Collateral Agent INDENTURE Dated as of March[], 2016 0% Convertible Senior Secured Notes due 2020... (Filed With SEC on March 15, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 15, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 10, 2015)
- CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THEOMITTED MATERIAL HAS BEEN FILED SEPARATELY... (Filed With SEC on November 10, 2014)
- OREXIGEN THERAPEUTICS, INC. AS ISSUER 2.75% CONVERTIBLE SENIORNOTES DUE 2020 INDENTURE DATED AS OF DECEMBER 6,2013 WILMINGTON TRUST, NATIONAL ASSOCIATION AS TRUSTEE TABLE OF... (Filed With SEC on December 9, 2013)
- 11,000,000 Shares OREXIGEN THERAPEUTICS, INC. Common Stock, par value $0.001 per share UNDERWRITING AGREEMENT (Filed With SEC on October 25, 2012)
- OREXIGEN THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on December 15, 2011)
- OREXIGEN THERAPEUTICS, INC. (a Delaware corporation) 5,646,173 Units Each Unit Consisting of One Share of Common Stock And A Warrant to Purchase Ten Shares of Common Stock... (Filed With SEC on December 15, 2011)
- OREXIGEN THERAPEUTICS, INC. (a Delaware corporation) 10,000,000 Shares of Common Stock (Filed With SEC on July 27, 2009)
- OREXIGEN THERAPEUTICS, INC. (a Delaware corporation) 7,000,000 Shares of Common Stock PURCHASE AGREEMENT (Filed With SEC on January 24, 2008)
